Baseline intact fibroblast growth factor 23 and risk of kidney disease progression in the Indian Chronic Kidney Disease cohort: a prospective multicenter study
In this prospective cohort of Indian CKD patients, iFGF23 levels did not provide independent prognostic information after accounting for established risk factors. Routine iFGF23 testing has limited incremental prognostic value in this setting.
Authors
- Shubham Kumar Sharma (ORCID: https://orcid.org/0000-0001-9446-8074)
- Arpita Ghosh (ORCID: https://orcid.org/0000-0003-0036-4376)
- Vivek Kumar (ORCID: https://orcid.org/0000-0003-1306-7610)
- Ashok Yadav (ORCID: https://orcid.org/0000-0001-6787-3883)
- Kajal Kamboj
- Aman Rastogi
- Love Jain
- Indian Chronic Kidney Disease Study Network
- Vivekanand Jha
Institutions
- Manipal Academy of Higher Education (IN)
- George Institute for Global Health (IN)
- Post Graduate Institute of Medical Education and Research (IN)
- Imperial College London (GB)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fmed.2025.1707350
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00